Company Filing History:
2 out of 7 
1 out of 1 Years Active: 2014-2018
Title: The Innovative Contributions of Sophie Anne Michèle Bozonnet
Introduction
Sophie Anne Michèle Bozonnet is a notable inventor based in Gagnac-sur-Garonne, France. He has made significant contributions to the field of pharmaceutical and dermatological compositions. With a total of 3 patents to his name, his work focuses on the synthesis of dextrans with unique properties.
Latest Patents
Bozonnet's latest patents include innovative pharmaceutical compositions and dermatological compositions synthesized from catalytic domains that produce highly α-1,2 branched dextrans. The first patent describes an isolated polypeptide with glycosyl transferase enzymatic activity for producing dextrans with α(1→2) sidechains. This invention includes at least one region for bonding to glucan and a catalytically active region situated beyond the glucan bonding area. Additionally, it relates to polynucleotides coding for these enzymes and vectors containing the same. The second patent mirrors the first, emphasizing the prebiotic composition or pharmaceutical composition synthesized from similar catalytic domains.
Career Highlights
Throughout his career, Bozonnet has worked with esteemed institutions such as the Institut National des Sciences Appliquées (INSA). His research and innovations have contributed to advancements in the field of biochemistry and pharmaceuticals.
Collaborations
Some of his notable coworkers include Magali Martine Claude Remaud-Simeon and Pierre Emmanuel Frédéric Monsan. Their collaborative efforts have further enhanced the impact of Bozonnet's inventions.
Conclusion
Sophie Anne Michèle Bozonnet's work exemplifies the spirit of innovation in the pharmaceutical and biochemistry sectors. His patents reflect a commitment to advancing scientific knowledge and improving health outcomes through innovative compositions.